5/5Nutex Health, Inc. (NUTX): Non-reliance / restatement

Market data

Price before filing: $92.75 (2025-08-20 close, split/dividend-adjusted)
Market cap at flag: $644.5M (2025-08-21) · Latest: $1.28B (2026-10-16)

What happened next

Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.

Insider trading around this filing

90 days before the flag: no open-market insider sales or purchases reported.
30 days after: none reported.

Open-market purchases and sales (Form 4 codes P and S) by officers, directors and 10% owners, by transaction date, from 2025-05-23 to 2025-09-20. Excludes option exercises, grants, gifts and tax withholding. Amended filings replace the originals; joint filings count once. Foreign private issuers do not file Form 4. Many insider sales are pre-scheduled (10b5-1 plans) and are not by themselves a sign of wrongdoing.

Verified excerpt

"Accordingly, investors and all other persons should no longer rely upon the Previously Issued Financial Statements included in each of the Original Form 10-K and the Original Form 10-Q."

Quoted from the filing. Source

What this means

The company says previously issued financial statements (or the auditor's report on them) should no longer be relied upon (8-K Item 4.02). Non-reliance on the financial statements themselves is one of the most serious accounting red flags: past reported numbers were wrong and will be restated.

Scope: previously issued financial statements

Why this score: also within 90 days: Late quarterly report (NT 10-Q)